Clinical Trials Logo
  1. Home
  2. Other
  3. NCT00491829

Flibanserin Versus Placebo in Premenopausal Women With HSDD

Sexual Dysfunctions, Psychological Clinical Trial

Official title:
A Twenty-Four Week, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in Premenopausal European Women With Hypoactive Sexual Desire Disorder

Clinical Trial Summary

To establish efficacy of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in 6-month treatment, vs placebo for Hypoactive Sexual Desire Disorder in premenopausal European women.

To evaluate safety and tolerability of flibanserin in such patients.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

  • Sexual Dysfunctions, Psychological
Clinical Trial Details
NCT number NCT00491829
Study type Interventional
Source Sprout Pharmaceuticals, Inc
Contact
Status Completed
Phase Phase 3
Start date June 2007
Completion date March 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT00996372 - Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women Phase 3
Completed NCT00996164 - Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder Phase 3
Recruiting NCT05777031 - Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease Phase 4
Completed NCT01188720 - Sexual Health on Antidepressants Through Physical Exercise N/A
Completed NCT00175539 - Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties N/A
Completed NCT04792177 - Internet-based Emotion Regulation Intervention for Sexual Health N/A
Completed NCT02381912 - Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer N/A
Completed NCT03241524 - Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women N/A
Completed NCT00034021 - Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction Phase 2
Recruiting NCT05489133 - Early Psychological Intervention After Rape N/A
Completed NCT03775239 - Mindfulness as Treatment of Sexological Problems N/A
Completed NCT01654458 - A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer N/A
Completed NCT01188603 - Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD) Phase 1
Completed NCT01771237 - HIV Prevention Among Vulnerable Male Youth N/A
Completed NCT00360243 - 6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA Phase 3
Completed NCT00360555 - A Twenty Four Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder Phase 3
Completed NCT00360529 - 24-Week Placebo-Controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder Phase 3
Recruiting NCT05456919 - Quality of Sexual Function in BRCA Mutated Women
Terminated NCT01057901 - Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America Phase 3
Terminated NCT01040208 - 12 Week Safety Trial of Flibanserin in Depressed Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire and Distress Phase 3